N-nitrosamine impurities, a class of potentially carcinogenic substances, have become a significant concern in the pharmaceutical industry. These compounds can form during the drug manufacturing process or due to degradation.
Blog
Choosing the Right Tool for the Quality Job: 6 Key Considerations for Your Quality Management System
Choosing the right QMS is an investment in your organization’s future. By carefully considering these factors, you can select a system that empowers your quality goals, streamlines operations, and sets you on the path to continuous improvement.
As technology continues to advance, the integration of artificial intelligence (AI) into GMP environments promises enhanced efficiency, productivity, and quality control. However, alongside these benefits come unique challenges and considerations, particularly concerning regulatory compliance.
Automating digital data management in biopharmaceutical manufacturing is a process of using digital technologies such as cloud, artificial intelligence, data lakes, and wearables to collect, store, analyze, and share data across the entire development lifecycle.
Restricted Access Barrier Systems (RABS) have emerged as a cutting-edge technology to address challenges, providing a robust solution for aseptic processing in pharmaceutical and biotechnology industries. In this article, we will delve into what RABS technologies are and explore the steps involved in their successful implementation.